Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases. [electronic resource]
Producer: 20150812Description: 183-6 p. digitalISSN:- 1651-2081
- Adult
- Blepharospasm -- drug therapy
- Botulinum Toxins, Type A -- administration & dosage
- Cost Savings
- Drug Administration Schedule
- Dystonia -- drug therapy
- Female
- Hemifacial Spasm -- drug therapy
- Humans
- Injections, Intramuscular
- Male
- Neuromuscular Agents -- administration & dosage
- Torticollis -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.